+

EP3078365A1 - Agents solubilisants et compositions aqueuses les comprenant - Google Patents

Agents solubilisants et compositions aqueuses les comprenant Download PDF

Info

Publication number
EP3078365A1
EP3078365A1 EP16164501.5A EP16164501A EP3078365A1 EP 3078365 A1 EP3078365 A1 EP 3078365A1 EP 16164501 A EP16164501 A EP 16164501A EP 3078365 A1 EP3078365 A1 EP 3078365A1
Authority
EP
European Patent Office
Prior art keywords
polyglyceryl
glucoside
caprate
sodium
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP16164501.5A
Other languages
German (de)
English (en)
Other versions
EP3078365B1 (fr
Inventor
Martine Seu-Salerno
Laurence Fillardet
Hisatoshi NODA
Ryota ISHIMURA
Kenji Nishimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daito Kasei Industries France
Original Assignee
Daito Kasei Industries France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daito Kasei Industries France filed Critical Daito Kasei Industries France
Priority to EP16164501.5A priority Critical patent/EP3078365B1/fr
Publication of EP3078365A1 publication Critical patent/EP3078365A1/fr
Application granted granted Critical
Publication of EP3078365B1 publication Critical patent/EP3078365B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/604Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26Optical properties
    • A61K2800/262Transparent; Translucent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/49Solubiliser, Solubilising system

Definitions

  • the present invention concerns new solubilizing agents, in particular new agents for solubilizing fatty phase(s) in aqueous compositions.
  • the gemini surfactant is choosen from the group consisting of: poly(sodium decylglucoside hydroxypropylphosphate), poly(sodium laurylglucoside hydroxypropylphosphate), poly(sodium cocoylglucoside hydroxypropylphosphate and mixtures thereof).
  • the gemini surfactant has the following formula (A'): wherein s is an integer comprised from 1 to 20, preferably from 1 to 5, and R' represents a linear or branched alkyl group comprising from 1 to 26 carbon atoms, preferably from 1 to 18, and more preferably from 1 to 12, carbon atoms.
  • both R 5 and R 6 represent H.
  • R 7 represents -(CH 2 ) 2 -COOX 1 , X 1 being as defined above.
  • alkylpolyglucosides result from the condensation reaction of fatty alcohol(s) and of glucose or one of its derivatives.
  • capryl/caprylyl glucoside results from the condensation reaction of a mixture of caprylic and decyl alcohols, with glucose.
  • alkylpolyglucosides are blends of alkylpolyglucosides having different alkyl chain lengths, and/or having various degree of polymerization, namely various glucose (or glucose derivative) units.
  • preferred alkylpolyglucosides are those in which R a consists:
  • the fatty acid is selected from the group consisting of: caprylic acid, capric acid, oleic acid, lauric acid, myristic acid, ricinoleic acid, palmitic acid, stearic acid, arachidic acid, isostearic acid, behenic acid, and their mixtures.
  • the polyglycerol fatty acid(s) ester according to the invention is selected from the group consisting of: polyglyceryl-4 caprylate/caprate, polyglyceryl-5 caprylate/caprate, polyglyceryl-6 caprylate/caprate, polyglyceryl-7 caprylate/caprate, polyglyceryl-8 caprylate/caprate, polyglyceryl-9 caprylate/caprate, polyglyceryl-10 caprylate/caprate, polyglyceryl-3 caprate, polyglyceryl-4 caprate, polyglyceryl-5 caprate, polyglyceryl-6 caprate, polyglyceryl-7 caprate, polyglyceryl-8 caprate, polyglyceryl-9 caprate, polyglyceryl-10 caprate, polyglyceryl-10 decastearate, polyglyceryl-3 diisostearate, polyglyceryl-10 diisostearate, polyglyceryl-4 laurate, polyglyceryl-5 laurate, polyglyceryl-6
  • polyglycerol fatty acid(s) ester is polyglyceryl-6 laurate or polyglyceryl-4 caprate.
  • polyglycerol fatty acid(s) ester is polyglyceryl-6 laurate commercialized under the trade name HEXAGLYN 1-L from NIKKOL or S-FACE L-601 from SAKAMOTO.
  • composition according to the invention comprises a mixture of polyglyceryl-6 laurate and polyglyceryl-4 caprate.
  • the composition according to the invention comprises from 1% to 60%, preferably from 2% to 50%, and more preferably from 5% to 40% by weight of polyglycerol fatty acid(s) ester(s), based on the total weight of the composition.
  • the composition comprises from 15% to 40%, preferably from 20% to 30%, and more preferably from 25% to 30% by weight of polyglycerol fatty acid(s) ester(s), based on the total weight of the composition.
  • the content of polyglycerol fatty acid(s) ester(s) in the composition according to the invention corresponds to the total content of polyglycerol fatty acid(s) ester(s) in said composition.
  • the content of polyglycerol fatty acid(s) esters in the composition corresponds to the sum of the content of each polyglycerol fatty acid(s) ester in the composition.
  • sugar fatty acid(s) ester means an ester of sugar and of at least one fatty acid.
  • a sugar fatty acids ester is an ester of sugar and of a mixture of different fatty acids.
  • the fatty acid is a linear or branched, saturated or unsaturated, carboxylic acid, comprising from 4 to 36 carbon atoms, preferably 4 to 22 carbon atoms, more preferably 6 to 12 carbon atoms.
  • the composition according to the invention is alcohol-free.
  • the solubilizing agent according to the invention is advantageously efficient at low concentrations for solubilizing fatty phase in aqueous compositions. This is particularly interesting in view of reducing, or even avoiding the impact of surfactants on skin, such as skin irritations...
  • the vegetable oils are selected from the group consisting of: almond oil, apricot kernel oil, jojoba oil, argan oil, shear butter, grape seed oil, avocado oil, macadamia oil, sunflower oil, and mixture thereof.
  • the aqueous composition C2 is a cosmetic composition.
  • compositions were prepared as follows:
  • compositions without sucrose laurate Compositions without sucrose laurate
  • compositions A1 to A14 were prepared and are disclosed in the following table 1: Table 1 b: Compositions A15 to A20 X1 X2 X3 X4 X5 X6
  • APG Caprylyl/Capryl Glucoside (60% by weight in water) 70% 70% 70% 70% 70% Polyglycerol fatty acid ester Polyglyceryl-4 Caprate 25% 25% 25% - - - Polyglyceryl-6 Laurate - - - 25% 25% 25% gemini Sodium dilauramidoglutamide lysine (29% by weight in water) 5% - - 5% - - Sodium bishydroxyethylglycinate Coco-glucosides crosspolymer (40% by weight in water) - 5% - 5% - - - - - 5% total 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
  • solubilizers A1 to A14 were compared with four commercialized surfactants for solubilizing a fatty phase in water: Solubilizer 1, Solubilizer 2, Solubilizer 3 and Solubilizer 4.
  • compositions C3 to C26 were prepared according to the protocol disclosed in section B above. The percentages are % by weight relative to the total weight of the composition.
  • compositions comprising only one ingredient
  • compositions M1 to M14 are not efficient for solubilizing a fatty phase. Indeed, only emulsions (2 phases) or cloudy (not clear) compositions are obtained.
  • compositions P1 to P21 are not efficient for solubilizing a fatty phase. Indeed, only emulsions (2 phases) or cloudy (not clear) compositions are obtained.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
EP16164501.5A 2015-04-10 2016-04-08 Agents solubilisants et compositions aqueuses les comprenant Active EP3078365B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16164501.5A EP3078365B1 (fr) 2015-04-10 2016-04-08 Agents solubilisants et compositions aqueuses les comprenant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15305534 2015-04-10
EP16164501.5A EP3078365B1 (fr) 2015-04-10 2016-04-08 Agents solubilisants et compositions aqueuses les comprenant

Publications (2)

Publication Number Publication Date
EP3078365A1 true EP3078365A1 (fr) 2016-10-12
EP3078365B1 EP3078365B1 (fr) 2020-03-04

Family

ID=52875640

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16164501.5A Active EP3078365B1 (fr) 2015-04-10 2016-04-08 Agents solubilisants et compositions aqueuses les comprenant

Country Status (3)

Country Link
EP (1) EP3078365B1 (fr)
DK (1) DK3078365T3 (fr)
ES (1) ES2781424T3 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018090542A (ja) * 2016-12-05 2018-06-14 日光ケミカルズ株式会社 可溶化剤
WO2020035245A1 (fr) 2018-08-17 2020-02-20 Beiersdorf Ag Composition nettoyante
DE102020206649A1 (de) 2020-05-28 2021-12-02 Henkel Ag & Co. Kgaa Haarzusammensetzungen, umfassend ein glukosebasiertes haarkonditionierungsmittel und ein gemini-tensid
KR102386119B1 (ko) * 2021-08-06 2022-04-14 바이오스펙트럼 주식회사 피이지프리 천연 복합 가용화제 조성물
CN114948771A (zh) * 2022-03-17 2022-08-30 广东丸美生物技术股份有限公司 一种含四氢姜黄素的组合物及其制备方法、护肤品
CN115151237A (zh) * 2019-09-19 2022-10-04 化工产品开发公司Seppic 具有良好喷雾特性的稳定加香组合物
CN115282076A (zh) * 2022-07-28 2022-11-04 广州洁生日化有限公司 一种口腔护理清洁片及其制备方法及其使用方法
GB2606854A (en) * 2021-04-15 2022-11-23 Henkel Ag & Co Kgaa Clear, skin-compatible deodorants or antiperspirants
EP4349174A1 (fr) * 2022-10-05 2024-04-10 The Procter & Gamble Company Composition antimicrobienne comprenant un glycoside d'alkyle modifié et un alcènediol
US12090223B2 (en) 2020-12-14 2024-09-17 The Procter & Gamble Company Method of manufacturing cosmetic compositions comprising sucrose esters and solvents
US12171855B2 (en) 2020-12-14 2024-12-24 The Procter & Gamble Company Cosmetic compositions comprising sucrose esters and solvents

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3127399B1 (fr) * 2021-09-30 2025-01-10 Oreal Emulsion H/E avec C-glycoside et tensioactifs spécifiques

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789371A (en) * 1997-04-22 1998-08-04 Rhodia Inc. Amphoteric surfactants having multiple hydrophobic and hydrophilic groups
WO2005039642A1 (fr) * 2003-10-24 2005-05-06 University Of Saskatchewan Apport d'adn utilisant des tensioactifs cationiques gemines
US20140121174A1 (en) * 2012-10-25 2014-05-01 Henkel Ag & Co. Kgaa Anti-dandruff hair care products with selective active ingredients and a cationic keratin
WO2014076136A1 (fr) * 2012-11-13 2014-05-22 Galderma S.A. Composition d'emulsion de lavage au bpo
WO2015054135A1 (fr) * 2013-10-07 2015-04-16 Presperse Corporation Compositions à phase interne élevée renfermant un tensioactif gemini

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789371A (en) * 1997-04-22 1998-08-04 Rhodia Inc. Amphoteric surfactants having multiple hydrophobic and hydrophilic groups
WO2005039642A1 (fr) * 2003-10-24 2005-05-06 University Of Saskatchewan Apport d'adn utilisant des tensioactifs cationiques gemines
US20140121174A1 (en) * 2012-10-25 2014-05-01 Henkel Ag & Co. Kgaa Anti-dandruff hair care products with selective active ingredients and a cationic keratin
WO2014076136A1 (fr) * 2012-11-13 2014-05-22 Galderma S.A. Composition d'emulsion de lavage au bpo
WO2015054135A1 (fr) * 2013-10-07 2015-04-16 Presperse Corporation Compositions à phase interne élevée renfermant un tensioactif gemini

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
CASTRO M J L ET AL: "SYNERGISTIC EFFECTS OF ALKYL GLUCOSIDES AND NONIONIC SUGAR-BASED GEMINI SURFACTANTS//SYNERGISTISCHE EFFEKTE VON ALKYLGLUCOSIDEN UND NICHTIONISCHEN GEMINI-ZUCHERTENSIDEN", TENSIDE, SURFACTANTS, DETERGENTS, CARL HANSER VERLAG, MUNCHEN, DE, vol. 39, no. 2, 1 February 2002 (2002-02-01), pages 28 - 30, XP001112743, ISSN: 0932-3414 *
DATABASE GNPD [online] MINTEL; 1 November 2014 (2014-11-01), ANONYMOUS: "GNPD - Active Surge Eye Cream", XP055213131, retrieved from Mintel accession no. 2769661 Database accession no. 2769661 *
GAO ET AL., JAOCS, vol. 71, no. 7, July 1994 (1994-07-01), pages 771
GRIFFIN WC: "Calculation of HLB Values of Non-lonic Surfactants", JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS, vol. 5, 1954, pages 259
GRIFFIN WC: "Classification of Surface- Active Agents by 'HLB", JOURNAL OFTHE SOCIETY OF COSMETIC CHEMISTS, vol. 1, 1949, pages 311
MASUYAMA ET AL., 41 J. JAPAN CHEM. SOC., vol. 4, 1992, pages 301
MENGER ET AL., J. AM. CHEM. SOC., vol. 115, no. 2, 1993, pages 10083
MENGER ET AL., J. AM. CHEMICAL SOC., vol. 113, 1991, pages 1451
OKAHARA ET AL., J. JAPAN OIL CHEM. SOC., 1989, pages 746
ROSEN M J: "GEMINIS: A NEW GENERATION OF SURFACTANTS", CHEMTECH, WASHINGTON, DC, US, 1 March 1993 (1993-03-01), pages 30 - 33, XP000645619, ISSN: 0009-2703 *
ROSEN, CHEMTECH, March 1993 (1993-03-01), pages 30
ZHU ET AL., 68 JAOCS, vol. 7, 1991, pages 539
ZHU ET AL., JAOCS, vol. 67, no. 7, July 1990 (1990-07-01), pages 459
ZHU ET AL., JAOCS, vol. 69, no. 1, January 1992 (1992-01-01), pages 30
ZHU ET AL., JAOCS, vol. 69, no. 7, July 1992 (1992-07-01), pages 626

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018090542A (ja) * 2016-12-05 2018-06-14 日光ケミカルズ株式会社 可溶化剤
WO2020035245A1 (fr) 2018-08-17 2020-02-20 Beiersdorf Ag Composition nettoyante
CN115151237A (zh) * 2019-09-19 2022-10-04 化工产品开发公司Seppic 具有良好喷雾特性的稳定加香组合物
DE102020206649A1 (de) 2020-05-28 2021-12-02 Henkel Ag & Co. Kgaa Haarzusammensetzungen, umfassend ein glukosebasiertes haarkonditionierungsmittel und ein gemini-tensid
US12171855B2 (en) 2020-12-14 2024-12-24 The Procter & Gamble Company Cosmetic compositions comprising sucrose esters and solvents
US12090223B2 (en) 2020-12-14 2024-09-17 The Procter & Gamble Company Method of manufacturing cosmetic compositions comprising sucrose esters and solvents
GB2606854B (en) * 2021-04-15 2023-09-06 Henkel Ag & Co Kgaa Clear, skin-compatible PEG-free deodorants or antiperspirants
GB2606854A (en) * 2021-04-15 2022-11-23 Henkel Ag & Co Kgaa Clear, skin-compatible deodorants or antiperspirants
KR102386119B1 (ko) * 2021-08-06 2022-04-14 바이오스펙트럼 주식회사 피이지프리 천연 복합 가용화제 조성물
CN114948771A (zh) * 2022-03-17 2022-08-30 广东丸美生物技术股份有限公司 一种含四氢姜黄素的组合物及其制备方法、护肤品
CN115282076B (zh) * 2022-07-28 2023-06-27 广州洁生日化有限公司 一种口腔护理清洁片及其制备方法及其使用方法
CN115282076A (zh) * 2022-07-28 2022-11-04 广州洁生日化有限公司 一种口腔护理清洁片及其制备方法及其使用方法
EP4349174A1 (fr) * 2022-10-05 2024-04-10 The Procter & Gamble Company Composition antimicrobienne comprenant un glycoside d'alkyle modifié et un alcènediol

Also Published As

Publication number Publication date
ES2781424T3 (es) 2020-09-02
EP3078365B1 (fr) 2020-03-04
DK3078365T3 (da) 2020-05-04

Similar Documents

Publication Publication Date Title
EP3078365B1 (fr) Agents solubilisants et compositions aqueuses les comprenant
JP2023552848A (ja) 1種または複数の(バイオ)アルカンジオールおよび活性成分を含む組成物
WO2013092080A1 (fr) Produit pour le soin du corps avec hydratation dermique améliorée
FR3015246A1 (fr) Composition cosmetique comprenant une huile, un tensioactif non ionique et un compose c-glycoside
ES2587337T3 (es) Composiciones cosméticas que contienen ésteres a base de 2-etilbutanol
EP3082754B1 (fr) Utilisation d'alkylpolyglycosides comme solubilisants de parfums et composition parfumante les comprenant
US8183298B2 (en) Fatty acid esters, processes for their production and for incorporation into cosmetic and/or pharmaceutical formulations
US12251457B2 (en) Self-neutralizing amino acid based cationic compositions
EP1212033B1 (fr) Composition cosmetique
EP0821936A2 (fr) Combinaisons de substances actives déodorantes à base d'acides de lanoline, de glycerides partiels et de combinaisons aryles
US20230081952A1 (en) Cleansing composition
EP0709082A2 (fr) Combinations des agents à base des acides de cire de laine et glycérides des acides gras saturés efficace contre la peau impure, des formes légères d'acné et propionibactérium acnés
ES2561160T5 (es) Preparaciones cosméticas que contienen ésteres a base de 2-butiloctanol
US20220135769A1 (en) Biobased glyceryl heptanoate ester compositions and methods of making and using the same
US7875653B2 (en) Emulsion comprising 1,2-alkanediols and polar oil components
EP1704898A1 (fr) Composition cosmétique protégée de l'oxydation par de l'huile de germe de riz
WO2020122087A1 (fr) Composition d'émulsion huile dans eau comprenant une huile d'éther
KR102532929B1 (ko) 피부 화장료용 조성물
ES2390631T3 (es) Composiciones cosméticas que contienen ésteres a base de ácido 2-propilheptanoico
JP7403299B2 (ja) オイルゲル組成物および化粧料
FR3120793A1 (fr) Agents solubilisants et compositions les comprenant
JP6106777B2 (ja) 皮膚外用剤
JP7142138B2 (ja) 難水溶性成分の溶解性を向上させる方法
WO2019044529A1 (fr) Composition à émulsion de type aqueux comprenant une huile d'éther
US20230355494A1 (en) Shaving composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170313

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180523

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190924

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: CH

Ref legal event code: NV

Representative=s name: MICHELI AND CIE SA, CH

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1239560

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200315

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016030904

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20200430

REG Reference to a national code

Ref country code: FI

Ref legal event code: FGE

REG Reference to a national code

Ref country code: EE

Ref legal event code: FG4A

Ref document number: E018884

Country of ref document: EE

Effective date: 20200325

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20200401169

Country of ref document: GR

Effective date: 20200615

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200604

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20200518

Year of fee payment: 5

Ref country code: EE

Payment date: 20200320

Year of fee payment: 5

Ref country code: GR

Payment date: 20200508

Year of fee payment: 5

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20200304

REG Reference to a national code

Ref country code: EE

Ref legal event code: HC1A

Ref document number: E018884

Country of ref document: EE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200604

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2781424

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20200902

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200729

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200704

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20200821

Year of fee payment: 5

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1239560

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200304

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016030904

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200408

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200430

26N No opposition filed

Effective date: 20201207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20210322

Year of fee payment: 6

REG Reference to a national code

Ref country code: EE

Ref legal event code: MM4A

Ref document number: E018884

Country of ref document: EE

Effective date: 20210430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210408

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20220630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210409

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220408

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20230327

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20230502

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240327

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240425

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240409

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20240409

Year of fee payment: 9

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20240430

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240430

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载